| Literature DB >> 25246171 |
Hong-Wei Chen1, Guo-Dong Liu2, Li-Jun Wu3,4.
Abstract
PURPOSE: To carry out a systematic review of the literature on arthroscopic-assisted management (all types) of tibial plateau fractures to gain a more comprehensive understanding of clinical outcomes with this surgical technique, specifically to determine whether this may be a viable technique for the management of tibial plateau fractures.Entities:
Keywords: Arthroscopic; Clinical; Fracture; Outcome; Radiological; Systematic review; Tibial plateau
Mesh:
Year: 2014 PMID: 25246171 PMCID: PMC4661207 DOI: 10.1007/s00167-014-3256-2
Source DB: PubMed Journal: Knee Surg Sports Traumatol Arthrosc ISSN: 0942-2056 Impact factor: 4.342
Fig. 1Flow diagram of study selection
Characteristics of studies included in the systematic review
| References | Study design | Patient number | Sex, % male | Mean age (range), years | Schatzker classification | Graft type | Fixation | Mean follow-up (range), months |
|---|---|---|---|---|---|---|---|---|
| Rossi et al. [ | Prospective | 46 | 45.6 | 48 (25–73) | II (41 %); III (59 %) | Compacted cancellous bone graft | 6.5 mm screw | NA |
| Chan et al. [ | Prospective | 54 | 46.3 | 48 (22–868) | I (2 %); II (39 %); III (7 %); IV (19 %); V (15 %); VI (19 %) (closed fracture) | Autogenous iliac crest bone graft or allogeneic bone graft | Kirschner wire | 87 (18–128) |
| Chan et al. [ | Prospective | 18 | 66.7 | 35 (23–45) | V (61 %); VI (39 %) (closed fracture) | Autogenous iliac crest bone graft | Kirschner wire | 48 (39–69) |
| Gill et al. [ | Prospective | 25 | 40.0 | 45 (17–74) | I (8 %); II (20 %); III (64 %); IV (8 %) | Coral hydroxyapatite bone graft substitute | 7.3 mm screw | 24 (12–35) |
| Lobenhoffer et al. [ | Prospective | 10 | 20.0 | 49 | AO/OTA classification: B1 (20 %); B2 (20 %); B3 (60 %) | Allogeneic bone graft | 7.3 mm screw | 52 (36–96) |
| Siegler et al. [ | Retrospective | 27 | 63.0 | 45 (18–79) | I–III (closed fracture) | Autograft or bone substitute | 6.5 mm screw | 59.5 (24–138) |
| Kayali et al. [ | Retrospective | 21 | 66.7 | 41 (23–77) | I–III (closed fracture) | Corticocancellous allograft | 6.5 mm screw | 38 (12–96) |
| Duan et al. [ | Retrospective | 39 | 71.8 | 36 (17–58) | I (10 %); II (31 %); III (23 %); IV (31 %); V (5 %) | Synthetic, autograft, and allograft | Screw | 33.6 (12–60) |
| Pogliacomi et al. [ | Retrospective | 18 | 72.2 | 36 (15–61) | I (22 %); II (33 %); III (33 %); IV (11 %) | Human or synthetic bone grafts | Screw; plate | NA |
| Asik et al. [ | Retrospective | 45 | 75.6 | 39 (15–68) | AO/ASIF classification B1 (20 %); B2 (26); B3 (43 %); C1 (7 %); C2 (2 %); C3 (2 %) (closed fracture) | Autogenous corticocancellous iliac bone graft | Screw | 36 (14–72) |
| van Glabbeek et al. [ | Retrospective | 20 | 60.0 | 49 (18–78) | I (35 %); II (50 %); IV (10 %); V (5 %) | Human allograft bone | Screw | 39 (27–64) |
| Roerdink et al. [ | Retrospective | 30 | 10.0 | 72 (57–92) | I (20 %); II (43 %); III (17 %); IV (10 %); V (7 %); VI (3 %) | Bone plug or methyl methacrylate | Screw; plate | 36 (24–60) |
AO/ASIF Association for Osteosynthesis/Association for the Study of Internal Fixation, AO/OTA AO-Müller/Orthopaedic Trauma Association, NA not available
Summary of clinical outcomes for studies included in the systematic review
| References | Mean clinical Rasmussen score (range) | Clinical Rasmussen score distribution, % | Mean radiological Rasmussen Score (range) | Radiological Rasmussen score distribution, % | Secondary osteoarthritis, |
|---|---|---|---|---|---|
| Rossi et al. [ | 28.2 | NA | NA | Excellent (11 %); good (85 %); fair (4 %) | 4 (8.6) (tibiofemoral osteoarthritis) |
| Chan et al. [ | 28.4 (19–30) | NA | 16.1 (12–18) | Excellent + good (96 %); fair + poor (4 %) | 10 (18.5) |
| Chan et al. [ | 26.6 (18–29) | Excellent (22 %); good (67 %); fair (11 %) | NA | Excellent (28 %); good (61 %); fair (11 %) | 3 (16.7) |
| Gill et al. [ | 27.5 (21–30) | Excellent (76 %); good (16 %); fair (4 %); poor (4 %) | NA | NA | NA |
| Lobenhoffer et al. [ | NA | Excellent (80 %); good (10 %) | NA | Excellent (90 %) | 0 |
| Siegler et al. [ | 25.5 (4–30) | NA | 8 | Excellent (38 %); good (38); fair (19 %); poor (5 %) | 10 (47.6) (early osteoarthritis) |
| Kayali et al. [ | NA | Excellent (62 %); good (28 %); fair (10 %) | NA | Excellent (52 %); good (33 %); fair (14 %) | 5 (24.0) |
| Duan et al. [ | 26 | Excellent (67 %); good (26 %); fair (8 %) | NA | NA | 0 |
| Pogliacomi et al. [ | NA | Excellent (44 %); good (39 %); fair (11 %); poor (6 %) | NA | Excellent (28 %); good (39 %); fair (22 %); poor (11 %) | 5 (27.8) |
| Asik et al. [ | NA | Excellent (35 %); good (54 %); fair (7 %); poor (4 %) | NA | NA | NA |
| Glabbeek et al. [ | NA | Excellent (75 %); good (15 %); fair (5 %); poor (5 %) | NA | NA | NA |
| Roerdink et al. [ | Median 9 without secondary displacement 8.7 with secondary displacement | Excellent (40 %); good (40 %); fair (10 %); poor (10 %) | NA | Excellent (20 %); good (43 %); fair (30 %); poor (7 %) | 8 (26.7) |
NA not available
Newcastle–Ottawa Scale quality assessment of studies included in the systematic review
| References | Rossi et al. [ | Chan et al. [ | Chan et al. [ | Gill et al. [ | Lobenhoffer et al. [ | Siegler et al. [ | Kayali et al. [ | Duan et al. [ | Pogliacomi et al. [ | Asik et al. [ | Glabbeek et al. [ | Roerdink et al. [ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selection | ||||||||||||
| (1) Representativeness of the exposed cohort | ||||||||||||
| (a) Truly representative of the average patient in the community | ||||||||||||
| (b) Somewhat representative of the average patient in the community | * | * | * | * | * | * | * | * | * | * | ||
| (c) Selected group of users, e.g., nurses, volunteers | * | * | ||||||||||
| (d) No description of the derivation of the cohort | ||||||||||||
| (2) Selection of the non-exposed cohort | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| (a) Drawn from the same community as the exposed cohort | ||||||||||||
| (b) Drawn from a different source | * | |||||||||||
| (c) No description of the derivation of the non-exposed cohort | ||||||||||||
| (3) Ascertainment of exposure | ||||||||||||
| (a) Secure record (e.g., surgical records) | * | * | * | * | * | * | * | * | * | * | * | * |
| (b) Structured interview | ||||||||||||
| (c) Written self-report | ||||||||||||
| (d) No description | ||||||||||||
| (4) Demonstration that outcome of interest was not present at start of study | ||||||||||||
| (a) Yes | * | * | * | * | * | * | * | * | * | * | * | * |
| (b) No | ||||||||||||
| Comparability | ||||||||||||
| (1) Comparability of cohorts on the basis of the design or analysis | ||||||||||||
| (a) Study controls for scores | * | * | * | * | * | * | * | * | * | * | * | * |
| (b) Study controls for any additional factor | ||||||||||||
| Outcome | ||||||||||||
| (1) Assessment of outcome | ||||||||||||
| (a) Independent blind assessment | ||||||||||||
| (b) Record linkage | * | * | * | * | * | * | * | * | * | * | * | * |
| (c) Self-report | ||||||||||||
| (d) No description | ||||||||||||
| (2) Was follow-up long enough for outcomes to occur | ||||||||||||
| (a) Yes (select an adequate follow-up period for outcome of interest) | * | * | * | * | * | * | * | * | * | * | * | * |
| (b) No | ||||||||||||
| (3) Adequacy of follow-up of cohorts | ||||||||||||
| (a) Complete follow-up—all subjects accounted for | * | * | * | * | * | * | * | * | * | * | ||
| (b) Subjects lost to follow-up unlikely to introduce bias |
| 25%* | ||||||||||
| (c) Follow-up rate and no description of those lost | ||||||||||||
| (d) No statement |
NA not applicable
* means yes